Missed Revenue and EPS Estimates: bluebird bio, Inc. (BLUE) Stock Plunging Deep in Early Trading.
Maria Masood
March 7, 2022
bluebird bio, Inc. (BLUE) is a company focusing on severe genetic diseases and engaged in the development of clinical portfolios for sickle cell anemia, thalassemia,